Feng Zhang, PhD
Core Member at Broad Institute of MIT and Harvard, Professor at Massachusetts Institute of Technology
2016 NYSCF – Robertson Stem Cell Prize Recipient
2014 NYSCF – Robertson Stem Cell Investigator
PhD, Stanford University
Postdoctoral Training, Harvard University
Bio
INVESTIGATOR
Dr. Zhang pioneered the development of CRISPR, a gene editing technique that can change, delete, and replace any genes in mammalian cells. By applying CRISPR to pluripotent stem cells, he can model complex disorders, such as psychiatric and neurological diseases, which are difficult to model using conventional methods, in order to develop novel therapeutic strategies for disease treatment. He and his lab are continuing to improve upon the CRISPR system and are making the technology available to scientists throughout the world. Dr. Zhang is also widely recognized for his work in optogenetics.
Watch a presentation by NYSCF – Robertson Investigator, Feng Zhang, PhD, who helped pioneer the revolutionary CRISPR gene editing tool.
PRIZE
Dr. Zhang wins the Prize for his development of the CRISPR-Cas9 gene editing system, using the technique in human cells. The CRISPR-Cas9 system and later advances, also developed by Zhang, are easy to execute with almost endless possibility for new research enabling scientists to change, delete, and replace any genes of any animal. His methods are being used in immunology, clinical medicine, and cancer biology.
External Links
Research Area
Mentioned In
- Our Community’s Top 10 Stem Cell and Neuroscience Breakthroughs of 2023
- World’s First CRISPR-Based Gene Therapy Approved by FDA
- Meet the 2023 NYSCF Stem Cell Heroes
- Beyond Bacteria: A New Gene Editing Tool Revealed in Complex Life
- Meet the Nano-Syringe that Could Revolutionize Gene Therapy
- Stem Cells, mRNA Vaccines, and Snakes: An Evening with Derrick Rossi
- The NYSCF Conference Returns in Person to Showcase Seminal Advances in Translational Stem Cell Research
- Media Advisory: The NYSCF Annual Conference on Translational Stem Cell Research
- Meet SEND: A ‘Mini FedEx Truck’ For Getting Treatments into Cells
- Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
- All Your Questions About the Science of COVID-19, Answered – Plus How Stem Cells Can Help
- Feng Zhang Develops Prototype for Faster, Cheaper COVID-19 Test
- New Solutions Are on the Horizon for COVID-19: Here’s How the NYSCF Community is Uniting to Push Them Forward
- For a Family Affected by Rare Disease, Stem Cells are Providing New Hope
- Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference
- CRISPR to the RESCUE: Gene Editing Technology Gets More Versatile
- CRISPR Gets an Upgrade Thanks to “Jumping Genes”
- Dr. Feng Zhang Launches New CRISPR Biotech to Create Better Diagnostic Tools
- Claims of First Gene-Edited Babies Spark Concerns
- Translational Research Takes Center Stage at NYSCF Conference
- International Society for Stem Cell Research Conference Showcases Promising Progress
- Dr. Feng Zhang Receives Grant From G. Harold and Leila Y. Mathers Foundation
- NIH Director Francis Collins To Deliver Keynote At 2018 NYSCF Conference
- Four NYSCF Innovators Named 2018 Howard Hughes Medical Institute Investigators
- NYSCF – Robertson Investigator Feng Zhang Launches “Beam Therapeutics”
- NYSCF – Robertson Investigator Feng Zhang Featured On 60 Minutes
- NYSCF — Robertson Investigator Feng Zhang Elected To American Academy Of Arts And Sciences
- CRISPR Gets A New Skill: Diagnosing Disease
- Two NYSCF — Robertson Investigators Awarded Vilcek Prize
- NYSCF-Supported Research Named Among Top Technical Advances of 2017
- New CRISPR Target: RNA
- CRISPR Gene Editing Technology Enables Novel RNA Research
- NYSCF Innovator Uses Gene Editing Technology to Screen Deadly Brain Cancer for Weaknesses
- NYSCF Innovator Feng Zhang Investigates the Role of Genetic Diversity in Future Gene Editing Treatments
- New Tools for Simultaneous, Multi-Gene Editing
- Feng Zhang Receives 2016 NYSCF – Robertson Stem Cell Prize
- Six NYSCF Innovators Named 2016 Faculty Scholars
- NYSCF – Robertson Investigator Feng Zhang Receives 2016 Canada Gairdner Award
- NYSCF – Robertson Investigator Feng Zhang Engineers Protein to Enhance DNA Editing
- NYSCF – Robertson Investigator Discovers New Proteins to Edit DNA
- NYSCF - Robertson Investigator Advances Genome Editing Technique
- NYSCF - Robertson Investigator Advances New Strategies for Tumor Genome Mapping
- NYSCF - Robertson Investigator Makes Progress in Genome Editing
- NYSCF Awards $9M to Six New NYSCF - Robertson Investigators